Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. DrugBank 薬物名（臨床試験情報から抽出） KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Elranatamab
(ANTI-CD3/ANTI-BCMA BISPECIFIC MONOCLONAL ANTIBODY PF-06863135)		1件: Elranatamab1件: Elranatamab 💬 1件: CD3E 💬 11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬1件: 28 💬
2 Linvoseltamab
(human IgG4-based anti-CD3 x anti-BCMA bispecific monoclonal antibody that binds to CD3 and BCMA)		1件: Linvoseltamab1件: Linvoseltamab 💬 1件: TNFRSF17 💬 2件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production 💬1件: 28 💬
3 Mezagitamab
(Anti-Cd38 monoclonal antibody TAK-079)		1件: Mezagitamab1件: Mezagitamab 💬 1件: CD38 💬 6件: Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬2件: 63, 66 💬
4 Muromonab
(Anti-CD3)		1件: ANTI-CD31件: Muromonab-CD3 💬 3件: CD3D,
CD3E,
CD3G 💬 		11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬3件: 60, 96, 97 💬
5 TNB-383B
(Anti-BCMA/Anti-CD3 T-cell Engaging Bispecific Antibody ABBV-383)		1件: TNB-383B---1件: 28 💬